Status:
TERMINATED
Thoracoscopic Lung Cancer Staging With the Use of Intraoperative Ultrasound
Lead Sponsor:
Joel Thompson, PhD
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
All patients undergoing video-assisted thoracoscopic (VATS) resection of lung cancer will receive standard therapy including lobectomy or sub-lobar resection and mediastinal lymph node dissection. Aft...
Eligibility Criteria
Inclusion
- Age ≥18 years. Eastern Cooperative Oncology Group performance status ≤2 (Karnofsky ≥60%, see Appendix A).
- Life expectancy of greater than 3 months
- Patients be able to undergo VATS resection as defined below:
- Preoperative Forced Expiratory Volume at one second ≥ 40% predicted
- OR
- Post-operative predicted Forced Expiratory Volume at one second ≥ 0.8 l
- Hg ≥ 8.0
- No evidence of coronary ischemia on stress evaluation Ability to understand and the willingness to sign a written informed consent document.
Exclusion
- Patients with surgery for a prior ipsilateral lung cancer
- Patients with known brain metastases
- Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements. (Patients with HIV are not excluded from this study)
Key Trial Info
Start Date :
July 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 27 2018
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT02218242
Start Date
July 1 2015
End Date
June 27 2018
Last Update
November 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kentucky, Markey Cancer Center
Lexington, Kentucky, United States, 40536